Healthcare provider profile · identity verified

Gilberto Antonio Riveron, MD

Allopathic & Osteopathic Physicians|Family Medicine · BONITA SPRINGS, FL · NPI 1124275896

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Gilberto Antonio Riveron, MD received $18.23 in general payments during 2025 across 1 reported records.

Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 162 claims for Ozempic by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$18.23

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$18.23	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$18.23	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Payment records were found, but the reported records did not identify a specific associated product for this analysis.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	162	39

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	887	299
Rosuvastatin Calcium	Rosuvastatin Calcium	710	243
Amlodipine Besylate	Amlodipine Besylate	706	230
Levothyroxine Sodium	Levothyroxine Sodium	650	186
Lisinopril	Lisinopril	498	160
Losartan Potassium	Losartan Potassium	427	135
Metoprolol Succinate	Metoprolol Succinate	425	139
Omeprazole	Omeprazole	355	138
Tamsulosin Hcl	Tamsulosin Hcl	315	111
Simvastatin	Simvastatin	294	88
Pantoprazole Sodium	Pantoprazole Sodium	290	107
Trazodone Hcl	Trazodone Hcl	252	97
Jardiance	Empagliflozin	251	68
Metformin Hcl	Metformin Hcl	250	89
Hydrochlorothiazide	Hydrochlorothiazide	245	84
Gabapentin	Gabapentin	242	83
Methylprednisolone	Methylprednisolone	213	181
Sertraline Hcl	Sertraline Hcl	198	55
Pravastatin Sodium	Pravastatin Sodium	192	64
Fluticasone Propionate	Fluticasone Propionate	186	108
Allopurinol	Allopurinol	183	57
Metoprolol Tartrate	Metoprolol Tartrate	179	56
Eliquis	Apixaban	174	55
Metformin Hcl Er	Metformin Hcl	169	55
Ozempic	Semaglutide	162	39
Zolpidem Tartrate	Zolpidem Tartrate	159	54
Ezetimibe	Ezetimibe	154	55
Furosemide	Furosemide	136	56
Famotidine	Famotidine	132	52
Alprazolam	Alprazolam	128	52
Valsartan	Valsartan	123	39
Clopidogrel	Clopidogrel Bisulfate	122	48
Escitalopram Oxalate	Escitalopram Oxalate	114	37
Carvedilol	Carvedilol	110	39
Albuterol Sulfate Hfa	Albuterol Sulfate	101	46
Montelukast Sodium	Montelukast Sodium	98	34
Mounjaro	Tirzepatide	98	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	91	32
Synthroid	Levothyroxine Sodium	91	23
Xarelto	Rivaroxaban	90	26
Glipizide	Glipizide	89	31
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	85	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	84	33
Citalopram Hbr	Citalopram Hydrobromide	83	32
Spironolactone	Spironolactone	78	27
Ibandronate Sodium	Ibandronate Sodium	77	32
Alendronate Sodium	Alendronate Sodium	75	29
Mirtazapine	Mirtazapine	75	26
Potassium Chloride	Potassium Chloride	75	32
Celecoxib	Celecoxib	74	33
Atenolol	Atenolol	66	18
Hydralazine Hcl	Hydralazine Hcl	64	21
Telmisartan	Telmisartan	61	18
Fluoxetine Hcl	Fluoxetine Hcl	59	20
Prednisone	Prednisone	58	34
Venlafaxine Hcl Er	Venlafaxine Hcl	58	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	19
Tramadol Hcl	Tramadol Hcl	54	36
Finasteride	Finasteride	52	20
Donepezil Hcl	Donepezil Hcl	49	19
Glimepiride	Glimepiride	49	17
Trulicity	Dulaglutide	48	11
Azithromycin	Azithromycin	46	42
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	46	39
Bumetanide	Bumetanide	45	12
Meloxicam	Meloxicam	45	26
Duloxetine Hcl	Duloxetine Hcl	44	11
Irbesartan	Irbesartan	44	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	43	37
Fenofibrate	Fenofibrate	43	13
Janumet	Sitagliptin Phos/Metformin Hcl	43	11
Januvia	Sitagliptin Phosphate	42	11
Paroxetine Hcl	Paroxetine Hcl	39	14
Amitriptyline Hcl	Amitriptyline Hcl	36	12
Clonazepam	Clonazepam	36	suppressed
Entresto	Sacubitril/Valsartan	36	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	36	15
Levetiracetam	Levetiracetam	35	suppressed
Ramipril	Ramipril	35	11
Diazepam	Diazepam	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	20
Esomeprazole Magnesium	Esomeprazole Magnesium	33	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	32	suppressed
Amoxicillin	Amoxicillin	32	27
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Bupropion Xl	Bupropion Hcl	30	11
Buspirone Hcl	Buspirone Hcl	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	11
Lovastatin	Lovastatin	30	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	18
Azelastine Hcl	Azelastine Hcl	27	16
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Nebivolol Hcl	Nebivolol Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	23
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	11
Tresiba Flextouch U-200	Insulin Degludec	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	24
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Torsemide	Torsemide	24	suppressed
Levemir Flexpen	Insulin Detemir	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Doxepin Hcl	Doxepin Hcl	22	suppressed
Estradiol	Estradiol	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	21
Pregabalin	Pregabalin	22	suppressed
Sildenafil Citrate	Sildenafil Citrate	22	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	18
Fenofibrate	Fenofibrate,micronized	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Jantoven	Warfarin Sodium	20	suppressed
Metformin Er Osmotic	Metformin Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Cephalexin	Cephalexin	19	16
Dexlansoprazole Dr	Dexlansoprazole	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Temazepam	Temazepam	19	suppressed
Erythromycin	Erythromycin Base	18	11
Ketoconazole	Ketoconazole	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Hydrocortisone	Hydrocortisone	16	12
Methocarbamol	Methocarbamol	16	12
Myrbetriq	Mirabegron	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Folic Acid	Folic Acid	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	11
Rabeprazole Sodium	Rabeprazole Sodium	14	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	13	suppressed
Silodosin	Silodosin	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Testosterone	Testosterone	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Kerendia	Finerenone	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$18.23 · 1 records	Novo Nordisk Inc	—	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error